Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges-Reference-Cited by-同舟云学术

Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges

Published:2013-04-06 Issue:3 Volume:5 Page:249-265
ISSN:1866-6116
Container-title:ADHD Attention Deficit and Hyperactivity Disorders
language:en
Short-container-title:ADHD Atten Def Hyp Disord

Author:

López Frank A.,Leroux Jacques R.

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Clinical Psychology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12402-013-0106-x.pdf

Reference103 articles.

1. Able SL, Johnston JA, Adler LA, Swindle RW (2007) Functional and psychosocial impairment in adults with undiagnosed ADHD. Psychol Med 37(1):97–107. doi: 10.1017/S0033291706008713

2. Adler LD, Nierenberg AA (2010) Review of medication adherence in children and adults with ADHD. Postgrad Med 122(1):184–191. doi: 10.3810/pgm.2010.01.2112

3. Adler LA, Goodman DW, Kollins SH, Weisler RH, Krishnan S, Zhang Y, Biederman J (2008) Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 69(9):1364–1373

4. Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T (2009) Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study. J Clin Psychopharmacol 29(3):239–247. doi: 10.1097/JCP.0b013e3181a390ce

5. American Academy of Pediatrics (2011) ADHD: clinical Practice Guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 128:1007–1022

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine—A literature review;Human Psychopharmacology: Clinical and Experimental;2024-07-18

2. Pharmacotherapy for ADHD in children and adolescents: A summary and overview of different European guidelines;European Journal of Pediatrics;2023-12-14

3. Treatment Outcomes With Licensed and Unlicensed Stimulant Doses for Adults With Attention-Deficit/Hyperactivity Disorder;JAMA Psychiatry;2023-10-25

4. Evidence-based pharmacological treatment options for ADHD in children and adolescents;Pharmacology & Therapeutics;2022-02

5. Pharmacotherapy in Prader-Willi Syndrome;Management of Prader-Willi Syndrome;2022